Goldman Sachs’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.22M Sell
5,503,141
-350,833
-6% -$396K ﹤0.01% 2628
2025
Q1
$8.55M Buy
5,853,974
+3,747,397
+178% +$5.47M ﹤0.01% 2343
2024
Q4
$4.49M Sell
2,106,577
-56,026
-3% -$119K ﹤0.01% 2937
2024
Q3
$6.06M Buy
2,162,603
+632,556
+41% +$1.77M ﹤0.01% 2621
2024
Q2
$3.57M Buy
1,530,047
+235,401
+18% +$548K ﹤0.01% 2852
2024
Q1
$5.79M Sell
1,294,646
-2,042,568
-61% -$9.13M ﹤0.01% 2456
2023
Q4
$10.7M Buy
3,337,214
+1,929,258
+137% +$6.19M ﹤0.01% 2023
2023
Q3
$4.46M Sell
1,407,956
-92,016
-6% -$292K ﹤0.01% 2561
2023
Q2
$7.45M Buy
1,499,972
+345,447
+30% +$1.72M ﹤0.01% 2272
2023
Q1
$5.7M Sell
1,154,525
-463,600
-29% -$2.29M ﹤0.01% 2434
2022
Q4
$10.2M Sell
1,618,125
-781,458
-33% -$4.92M ﹤0.01% 2121
2022
Q3
$25.9M Buy
2,399,583
+424,626
+22% +$4.59M 0.01% 1396
2022
Q2
$22.5M Sell
1,974,957
-987,252
-33% -$11.3M 0.01% 1539
2022
Q1
$27M Buy
2,962,209
+1,138,944
+62% +$10.4M 0.01% 1513
2021
Q4
$27.2M Sell
1,823,265
-156,447
-8% -$2.33M 0.01% 1543
2021
Q3
$50.9M Buy
1,979,712
+264,325
+15% +$6.79M 0.01% 1087
2021
Q2
$44.7M Buy
1,715,387
+434,309
+34% +$11.3M 0.01% 1159
2021
Q1
$45.2M Sell
1,281,078
-108,588
-8% -$3.83M 0.01% 1096
2020
Q4
$35.1M Buy
1,389,666
+548,316
+65% +$13.8M 0.01% 1194
2020
Q3
$31.7M Buy
841,350
+586,883
+231% +$22.1M 0.01% 1174
2020
Q2
$10.9M Buy
254,467
+67,739
+36% +$2.9M ﹤0.01% 1891
2020
Q1
$3.63M Buy
186,728
+11,594
+7% +$225K ﹤0.01% 2438
2019
Q4
$4.55M Buy
175,134
+69,888
+66% +$1.82M ﹤0.01% 2485
2019
Q3
$2.87M Buy
105,246
+26,474
+34% +$721K ﹤0.01% 2649
2019
Q2
$2.12M Buy
78,772
+15,561
+25% +$418K ﹤0.01% 2774
2019
Q1
$1.83M Buy
63,211
+1,924
+3% +$55.6K ﹤0.01% 2990
2018
Q4
$1.65M Buy
+61,287
New +$1.65M ﹤0.01% 2886